📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Metrion Biosciences

1.1 - Company Overview

Metrion Biosciences Logo

Metrion Biosciences

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.

Products and services

  • Cardiac Safety Screening: Delivers CiPA-compliant cardiac safety screening services using human cardiac ion channel assays, including GLP hERG assays, for safety assessment
  • High-Throughput Screening (HTS): Supplies high-throughput ion channel screening assays for hit finding, lead optimization, and selectivity profiling, supporting drug discovery for pharmaceutical and bioscience customers
  • Ion Channel Screening: Delivers validated ion channel screening assays using various platforms for drug discovery and safety assessment for pharmaceutical and bioscience customers worldwide

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Metrion Biosciences

Canopy Biosciences Logo

Canopy Biosciences

HQ: United States Website
  • Description: Provider of biotechnological products and services for gene editing and personalized medicine, including TUNR technology targeting translation elongation by inserting polyA tracks to decrease mRNA levels. Offerings include CellScape for spatial biology and multi-omic imaging with biomarker quantification; ChipCytometry for quantitative protein biomarker measurement; NanoString nCounter gene expression analysis; single-cell transcriptome profiling; and clinical deep phenotyping.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Canopy Biosciences company profile →
Bachem Logo

Bachem

HQ: Switzerland Website
  • Description: Provider of full-service biochemicals to the pharma and biotech industry; an independent, technology-based company specializing in process development and GMP manufacturing of peptide and oligonucleotide APIs, complex organic molecules, and innovative research biochemicals. Offers research-grade and GMP peptides, oligonucleotide NCE development, commercial APIs and generics, catalog peptides, custom peptide synthesis, amino acid derivatives, and products for diagnostics and cosmetics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bachem company profile →
Argon Network Logo

Argon Network

HQ: United Kingdom Website
  • Description: Provider of an international network of independent healthcare agencies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Argon Network company profile →
EAG Laboratories Logo

EAG Laboratories

HQ: United States Website
  • Description: Provider of global scientific services across technology-related industries, offering materials testing & analysis; advanced microscopy (SEM, TEM, STEM); chemical analysis; battery materials analysis; biomedical analysis; and compositional analysis & material identification. Through multidisciplinary expertise in life, materials and engineering sciences, helps companies innovate and improve products, ensure quality and safety, and protect intellectual property.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EAG Laboratories company profile →
Nordic Bioscience Logo

Nordic Bioscience

HQ: Denmark Website
  • Description: Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nordic Bioscience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Metrion Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Metrion Biosciences

2.2 - Growth funds investing in similar companies to Metrion Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Metrion Biosciences

4.2 - Public trading comparable groups for Metrion Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Metrion Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Metrion Biosciences

What does Metrion Biosciences do?

Metrion Biosciences is a provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.

Who are Metrion Biosciences's competitors?

Metrion Biosciences's competitors and similar companies include Canopy Biosciences, Bachem, Argon Network, EAG Laboratories, and Nordic Bioscience.

Where is Metrion Biosciences headquartered?

Metrion Biosciences is headquartered in United Kingdom.

How many employees does Metrion Biosciences have?

Metrion Biosciences has 1,000 employees 🔒.

When was Metrion Biosciences founded?

Metrion Biosciences was founded in 2010 🔒.

What sector and industry vertical is Metrion Biosciences in?

Metrion Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Metrion Biosciences

Who are the top strategic acquirers in Metrion Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Metrion Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Metrion Biosciences?

Top strategic M&A buyers groups and sectors for Metrion Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Metrion Biosciences's sector and industry vertical

Which are the top PE firms investing in Metrion Biosciences's sector and industry vertical?

Top PE firms investing in Metrion Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Metrion Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Metrion Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Metrion Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Metrion Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Metrion Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Metrion Biosciences?

The key public trading comparables and valuation benchmarks for Metrion Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Metrion Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Metrion Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Metrion Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Metrion Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Metrion Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Metrion Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Metrion Biosciences

Launch login modal Launch register modal